Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity

Clinical Chemistry

Volumn 48, Issue 2, 2002, Pages 278-283

  Chan, Dick C ^a   Watts, Gerald F ^a   Barrett, P Hugh ^a   Mamo, John C L ^a   Redgrave, Trevor G ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B48; APOLIPOPROTEIN C3; CHOLESTEROL OLEATE; CHYLOMICRON; INSULIN; LIPOPROTEIN; REMNANT LIKE PARTICLE CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHEROGENESIS; CHEMOLUMINESCENCE; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; HUMAN; IMMUNOASSAY; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MASS SPECTROMETRY; OBESITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SCORING SYSTEM; TURBIDIMETRY;

EID: 0036150922     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.2.278     Document Type: Article

References (29)

1. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease
2. Triglyceride-rich lipoproteins and the progression of coronary artery disease
3. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-1 immunoaffinity mixed gels
4. Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma
5. Predictive value of remnant-like particle cholesterol as an indicator of coronary artery stenosis in patients with normal serum triglyceride levels
6. Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study
7. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: Results from the Framingham Heart Study
8. Remnant-like particle-cholesterol concentrations in patients with type 2 diabetes mellitus and end-stage renal disease
9. Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state
10. Ratio of remnant-like particle-cholesterol to serum total triglycerides is an effective alternative to ultracentrifugal and electrophoretic methods in the diagnosis of familial type III hyperlipoproteinemia
11. Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease
12. Postprandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B-48 in the fasting state
13. Quantitative determination of human apolipoprotein C-III by electroimmunoassay
14. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial
15. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo
16. Chylomicron remnant metabolism im familial dyslipidemias studied with a remnant-like emulsion breath test
17. Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice
18. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
19. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal
20. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
21. The usefulness of measuring body fat deposition for detecting obesity and atherogenicity in Japanese school children
22. Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women
23. Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: The Biguanides and the Prevention of the Risk of Obesity (BIGPRO) 1 study
24. Acute hyperinsulinemia decreases hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in normolipidaemic, non-diabetic subjects
25. In vivo stimulation of low-density lipoprotein degradation by insulin
26. Hepatic uptake of chylomicron remnants
27. Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein
28. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E
29. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity